Finally, no differences in MVD (assessed by CD34 immunostaining or by CD105 immunostaining) were observed concerning clinicopathological characteristics such as sex, age, tobacco smoking, tumor location and tumor size, suggesting that MVD in OSCC is not influenced by these parameters. This evidence concerns the gene CD34 and neoplasm.